『Between April 23 and Nov 4, 2020, 23 848 participants were enrolled and 11 636 participants (7548 in the UK, 4088 in Brazil) were included in the interim primary efficacy analysis.』
先不論幾期 AZ有辦法跨國找數萬的試驗者,並且依照年齡性別控制分組,以求減少對人種的誤差,你國產疫苗有辦法作到這樣?
The Oxford-AstraZeneca COVID-19 vaccine, ChAdOx1, is promising, effective against variant B.1.1.7, but minimally protective against variant B.1.351. ...
→
pttbest5566
台灣 05-31 16:00
···
United Kingdom:
Phase 2/3 trial
10,673 participants aged 18 years or older; priority for high-exposure professions
Brazil
Phase 3, single-blinded
10,002 participants aged 18 or older; priority for high-exposure professions